申请人:Fisons Limited
公开号:US04159273A1
公开(公告)日:1979-06-26
There are described compounds of formula I, ##STR1## in which R.sub.3 represents hydrogen, or alkyl C 1 to 6, R.sub.5 represents hydrogen, hydroxy, alkoxy C 1 to 6, alkanoyloxy C 2 to 6, alkenyloxy C 2 to 6, nitro, -NR.sub.1 R.sub.2, halogen, alkyl C 1 to 6, hydroxy-alkyl C 1 to 6, or hydroxy-alkoxy C 1 to 6, An adjacent pair of X, Y and Z form a --(CH.sub.2).sub.4 --, --CH.dbd.CH--CH.dbd.CH--or --O(CH.sub.2).sub.3 --chain, each of the chains optionally being substituted by one or two C 1 to 6 alkyl groups, and the remaining substituent X or Z represents alkenyl C2 to 6 optionally substituted by phenyl; halogen; or alkyl C 1 to 9 optionally substituted by one or more of the groups hydroxy, halogen, carbonyl oxygen, phenyl, or alkoxy C 1 to 6, Or, when an adjacent pair of X, Y and Z form a chain substituted by one or two C 1 to 6 alkyl groups, the remaining substituent X or Z may be hydrogen, and R.sub.1 and R.sub.2, which may be the same or different, are each hydrogen or alkyl C 1 to 6, And pharmaceutically acceptable derivatives thereof. Processes for making the compounds and pharmaceutical, e.g. anti-allergic, compositions containing the compounds are also described.
本文描述了一种化合物,其化学式为I,其中R.sub.3代表氢或烷基C1至6,R.sub.5代表氢、羟基、烷氧基C1至6、烷酰氧基C2至6、烯酰氧基C2至6、硝基、-NR.sub.1R.sub.2、卤素、烷基C1至6、羟基-烷基C1至6或羟基-烷氧基C1至6。相邻的X、Y和Z形成一个--(CH2)4--、--CH=CH-CH=CH-或--O(CH2)3--链,每个链可选地被一个或两个C1至6烷基取代,剩余的取代基X或Z代表烯基C2至6,可选地被苯基、卤素或烷基C1至9取代,该烷基可选地被一个或多个羟基、卤素、羰基氧、苯基或烷氧基C1至6的基团取代。或者,当相邻的X、Y和Z形成一个被一个或两个C1至6烷基取代的链时,剩余的取代基X或Z可以是氢,R.sub.1和R.sub.2可以相同或不同,分别代表氢或烷基C1至6。还描述了制备该化合物的方法以及含有该化合物的药物,例如抗过敏药物组成物。